New Zealand vs Chinese Taipei: Dealing with construction permits: Quality of building regulations
New Zealand
2 DB16-20 methodology
in 2019
Chinese Taipei
2 DB16-20 methodology
in 2019
New Zealand rank
1st
Chinese Taipei rank
1st
Dealing with construction permits: Quality of building regulations over time
- New Zealand
- Chinese Taipei
How they compare
New Zealand currently reports 2 DB16-20 methodology against 2 DB16-20 methodology in Chinese Taipei, a difference of 0 DB16-20 methodology.
Across all 6 years both countries report, Chinese Taipei has been ahead every year.
New Zealand ranks 1st and Chinese Taipei ranks 1st of 186 countries.
Frequently asked questions
- Which has higher dealing with construction permits: quality of building regulations, New Zealand or Chinese Taipei?
- New Zealand, at 2 DB16-20 methodology against 2 DB16-20 methodology in Chinese Taipei as of 2019.
- What is the difference in dealing with construction permits: quality of building regulations between New Zealand and Chinese Taipei?
- 0 DB16-20 methodology, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Chinese Taipei?
- 6 years are reported by both, from 2014 to 2019.
- How do New Zealand and Chinese Taipei rank globally for dealing with construction permits: quality of building regulations?
- New Zealand ranks 1st and Chinese Taipei ranks 1st of 186 countries.
- Where does this data come from?
- The World Bank, published as Dealing with construction permits: Quality of building regulations index (0-2) (DB16-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The quality of building regulations index evaluates the accessibility and transparency of building regulations. It has two components: (i) whether building regulations are easily accessible; and (ii) whether the requirements for obtaining a building permit are clearly specified. The index is computed based on the methodology in the DB16-20 studies.